NanoViricides Inc. (NNVC)

[FORZANANO]

Let's not forget the agreement signed by Dr.Eva Harris and NanoViricides on February 17, 2010.
I do not see why Eva would not support NNVC after this agreement.


NanoViricides signs research and development agreement with Dr. Eva Harris’s laboratory at UC Berkeley 17. February 2010 00:59


NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reports that it has signed a research and development agreement with Dr. Eva Harris’s laboratory at the University of California, Berkeley (UC Berkeley).

“We will now be able to rapidly advance our anti-dengue therapeutics program.”

Under this agreement, Dr. Harris and coworkers will evaluate the effectiveness of nanoviricides® drug candidates against various dengue viruses. Cell culture models as well as in vivo animal studies will be employed for testing the drug candidates.

The Company believes that a nanoviricide drug under development can be expected to be a broad-spectrum anti-dengue antiviral treatment capable of attacking all four dengue virus serotypes and their variant strains. Currently there are no approved vaccines for the prevention of dengue, nor drugs for treatment of dengue virus infection. The worldwide market size for an effective anti-dengue treatment may be as large as that for Hepatitis C virus treatment, or in the billions of dollars, based on current population exposure data.